【摘要】 目的 :评价再手术在肝癌复发治疗中的地位。方法 :回顾分析 1 988年～ 1 999年 30例肝癌复发再手术切除的随访资料。结果 :首次手术后 1、2、3和 5年总生存率分别为 93 .3 %、73 .3 %、56 .7%和 36.7%。第一次再手术后 1、3和 5年生存率分别为 63 .3 %、2 3 .3 %和 1 3 .3 %。肺叶切除后 1、3和 5年生存率分别为 71 .4%、42 .9%和 2 8.6 %。结论 :肝癌复发病人再手术后的预后与复发时肿瘤大小、数目、类型相关 ,再切除是肝癌复发的首选治疗方法更多还原

【Abstract】 To evaluate re resection in the treatment of recurrent hepatocellular carcinoma. Methods: Thirty patients with recurrent hepatocarcinoma re resected were followed up and thire post operative survival data were analyzed. Results:The sur vival rate of 1, 2, 3 and 5 year in the 30 cases were 93.3%, 73.3%, 56.7% and 36.7% respectively, with the median survival term of 18.5 months, and average of 26.0 months. The preliminary results were encouraging. Conclusions: The size and pathological type of recurrent hepatocarcinoma are factors influencing the prognosis of patients. Re resection of recurrent HCC could markedly prolong the patients’ survival term.更多还原